Horizon Discovery

124 articles about Horizon Discovery

• Horizon Discovery Ltd. Strengthens Board With Appointment of Dr. Ian Gilham

  8/1/2013

• Mirna Therapeutics, Inc. and Horizon Discovery Ltd. Publication Elucidates Novel miR-34 Tumor Suppressor Pathway, Underscores miR-34 as Important Anticancer Approach

  6/26/2013

• Horizon Discovery Ltd. Establishes Two New Centers of Excellence in Cambridge, UK

  3/11/2013

• Horizon Discovery Ltd. Launches SyntheTx Partnership Program to Identify Novel Targets for Cancer Therapeutics

  10/5/2012

• Horizon Discovery Ltd. and H3 Biomedicine Inc. Collaborate to Identify and Validate Novel, Patient-Relevant Cancer Targets

  4/30/2012

• Horizon Discovery Ltd. Announces Strategic Partnership with Promega Corporation to Develop Next-Generation Predictive Human Disease Models

  11/7/2011

• Horizon Discovery Ltd. Announces $18.6 Million Expansion Cash

  9/15/2011

• Horizon Discovery Ltd. Introduces Panel of Molecular Diagnostic Reference Standards

  9/13/2011

• Horizon Discovery Ltd. Expands Commercial Division with Senior Appointments and Establishes a Larger UK Premises

  8/9/2011

• Horizon Discovery Ltd. Receives $1.6M Grant Funding from EU FP7 Program and Joins the COLTHERES Consortium

  3/31/2011

• Horizon Discovery Ltd. Secures Exclusive License from University of Pittsburgh to Panel of New Human Isogenic Cell Lines

  2/23/2011

• Horizon Discovery Ltd. Secures Exclusive License to Homologous Recombination Inventions from University of Minnesota

  2/1/2011

• Horizon Discovery Ltd. and University of Washington Announce Collaboration to Apply rAAV Gene Editing in iPS cells

  1/6/2011

• Horizon Discovery Ltd. to Support 50 Centers of Excellence in Human Cellular Gene-Editing

  12/14/2010

• Horizon Discovery Ltd. Secures License from Case Western Reserve University to 35 Endogenously Tagged Human Isogenic Cell Lines

  12/9/2010

• Horizon Discovery Ltd. and Mirna Therapeutics, Inc. to Test Activities of Tumor Suppressor MicroRNAs in X-MAN Models

  11/2/2010

• Horizon Discovery Ltd.'s X-MAN Cell-models Predict that a Subset of KRAS Mutated Cancers Respond to EGFR Therapy

  10/27/2010

• Horizon Discovery Ltd. and Cylene Pharmaceuticals, Inc. Collaborate in Rational Selection of Patients for Clinical Trial

  10/19/2010

• Horizon Discovery Ltd. Acquires Hypoxium and Launches Horizon Discovery Services Ltd

  10/5/2010

• Horizon Discovery Ltd. Closes £6.25M Series C Financing and Makes New Board Appointments

  9/28/2010